-
McIlroy's back-nine birdie run grabs share of Masters lead
-
Melania Trump blasts 'lies' linking her to Epstein
-
'Anxious' Tatum back at Madison Square Garden with NBA East second seed on line
-
Strait of Hormuz traffic remains becalmed despite ceasefire
-
Melania Trump denies any links to Epstein abuse
-
American Airlines targets April 30 return to Venezuela
-
Venezuela police tear-gas protesters demanding salary rises
-
Robertson to leave Liverpool at end of season
-
Choudhary smashes Lucknow to dramatic IPL win over Kolkata
-
Sean 'Diddy' Combs asks US appeals court to overturn sentence
-
Verstappen Red Bull future in doubt as engineer to join McLaren
-
France's Macron in Rome for first meeting with Pope Leo
-
Angola name former Senegal boss Cisse as new coach
-
Sinner and Alcaraz wobble but advance to Monte Carlo quarter-finals
-
Reed soars to early Masters lead on wings of eagles
-
US Democrats fail in bid to curb Trump's Iran war powers
-
Veteran prop Slimani to return to France with Toulon
-
Iranians pay tribute to slain supreme leader weeks after killing
-
Russian police raid independent Novaya Gazeta media outlet
-
Barton Snow completes Cheltenham-Aintree double in Foxhunters Chase
-
IMF to cut global growth forecast due to Mideast war
-
Jihadists kill Nigerian troops including senior brigadier general
-
Local boy Aranburu sprints to Basque Country stage, Seixas extends lead
-
Russia brands Nobel Prize-winning rights group Memorial 'extremist'
-
England set for World Cup warm-up friendlies in Florida heat
-
Sabalenka pulls out of Stuttgart Open with injury
-
BTS kick off world tour with spectacular South Korea show
-
UK animal charity rescues over 250 dogs from single home
-
Barton Snow has a lot to crow about in Foxhunters Chase
-
Reigning champion Nick Rockett out of Grand National
-
'Free' McIlroy launches his Masters repeat bid
-
US envoy warns EU won't win AI race 'bringing others down'
-
Trump, Vance not 'meddling' in Hungary vote, says US envoy to EU
-
Jihadists kill 18 Nigerian troops including senior brigadier general
-
Mideast war threatens Africa's supply of humanitarian medicine
-
Seven World Cup winners start for England in Women's Six Nations opener
-
China FM vows deeper ties with North Korea on trip to Pyongyang
-
Sinner survives energy dip, end of streak to see off Machac
-
IMF expects to provide vulnerable economies hit by Iran war up to $50 bn
-
Oil prices jump back toward $100 on Mideast ceasefire doubts
-
Player tells Tiger to 'get a chauffeur'
-
Believers rejoice as Jerusalem's holy sites re-open
-
EU lawmakers want to tax Big Tech to fund budget
-
Croke Park boss eager to stage Fury-Joshua heavyweight clash in Dublin
-
Cannes Festival promises escapism in Hollywood-lite edition
-
Stabbed for saying no: Is online misogyny fueling violence in Brazil?
-
Russia's Nobel Prize-winning rights group Memorial branded 'extremist'
-
McIlroy ready for early start as 90th Masters begins
-
Fonseca eases into Monte Carlo last eight meeting with Zverev
-
Verstappen set for fresh F1 angst as engineer nears Red Bull exit - reports
Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
JERSEY CITY, NJ / ACCESS Newswire / September 16, 2025 / Apprentice.io, the creator of the first AI-powered manufacturing platform for life sciences, today announced a strategic partnership with Aprecia, the industry leader in pharmaceutical three-dimensional printing (3DP). This collaboration marks a significant step forward in digitally connected drug manufacturing, combining cutting-edge AI technology with breakthrough 3DP innovation in drug delivery.
Through this partnership, Aprecia will implement Apprentice.io's intelligent manufacturing platform at its Ohio facility to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration will support Aprecia's mission to revolutionize how medications are produced and delivered using advanced additive manufacturing.
Apprentice's cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide flexibility, scalability, and connectivity appropriate for Aprecia's manufacturing model. As Aprecia continues to grow, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.
"I believe that Aprecia is the next generation of additive manufacturing," said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. "They are at the absolute forefront of innovation in life sciences. Combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future."
Aprecia's deployment of Apprentice's technology reflects a shared commitment for next level pharmaceutical manufacturing. The collaboration underscores the industry's rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.
"Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation, said Kyle Smith, president and chief operating officer at Aprecia. Our partnership with Apprentice.io strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what's possible in oral medication. We will continue to integrate cutting-edge technologies that keep us at the forefront and address the evolving needs of patients and caregivers."
About Aprecia
Aprecia has brought significant change to pharmaceutical manufacturing with advanced 3D printing technology, enhancing the speed, flexibility, and precision of oral medication production. Through strategic partnerships, Aprecia can create personalized medicine and accelerate market entry, setting new standards in the industry.
Located in Mason, Ohio, Aprecia's capabilities include pharmaceutical manufacturing, drug product development, engineering innovation, and analytical methods. For over 20 years, Aprecia has led in pharmaceutical additive manufacturing technologies, establishing 3D printing as a viable pharmaceutical manufacturing option and is continuously exploring ways to improve medicine and patient health outcomes. For more information, visit www.aprecia.com.
About Apprentice
Apprentice is the industry's first agentic manufacturing platform built for a world beyond paper and legacy MES. Apprentice unifies MES, LES, automation, and remote collaboration capabilities together in a modern, no-code platform while simultaneously deploying AI Agents to support every step of manufacturing. The AI Agents operate autonomously to amplify human efforts, optimize processes, and scale throughput while reducing costs. The company's technology drives innovation at every stage-from design and creation to simulation, execution, and optimization. For over a decade, we've helped life sciences companies integrate their people, processes, and systems into a single next-gen platform. Today, Apprentice serves all manufacturing sectors fulfilling the vision of what a digital "Apprentice" can be. For more information, visit www.apprentice.io.
Contact Information:
Kristen Kucks
Director of Communications, Marketing
[email protected]
Justin Foreman
[email protected]
SOURCE: Apprentice.io
View the original press release on ACCESS Newswire
O.Brown--AT